LEADER 04360nam 2200649Ia 450 001 9910830897703321 005 20230421035451.0 010 $a0-470-18796-4 010 $a1-282-30227-2 010 $a9786612302275 010 $a0-470-86646-2 010 $a0-585-29483-6 035 $a(CKB)111004366691960 035 $a(EBL)469049 035 $a(OCoLC)746576983 035 $a(SSID)ssj0000205256 035 $a(PQKBManifestationID)11171162 035 $a(PQKBTitleCode)TC0000205256 035 $a(PQKBWorkID)10192329 035 $a(PQKB)11060690 035 $a(MiAaPQ)EBC469049 035 $a(EXLCZ)99111004366691960 100 $a19951130d1996 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMonocyclic azepines$b[electronic resource] $ethe syntheses and chemical properties of the monocyclic azepines /$fGeorge R. Proctor, James Redpath 210 $aChichester ;$aNew York $cWiley$dc1996 215 $a1 online resource (634 p.) 225 1 $aThe chemistry of heterocyclic compounds ;$vv. 56 300 $a"A Wiley-Interscience publication." 311 $a0-471-96372-0 320 $aIncludes bibliographical references and index. 327 $aMonocyclic Azepines: The Syntheswes and Chemical Properties of the Monocyclic Azepines; Contents; Acknowledgements; List of Abbreviations; 1. Introduction; 2. Azepanes (Hexahydroazepines); 3. Azepanones; I. Azepan-2-ones (Caprolactams); II. Azepan-3-ones; III. Azepan-4-ones; 4. Azepanediones; I. Azepane-2,3-diones; II. Azepane-2,4-diones; III. Azepane-2,5-diones; IV. Azepane-2,6-diones; V. Azepane-2,7-diones; VI. Azepane-3,4-diones; VII. Azepane-3,5-diones; VIII. Azepane-3,6-diones*; IX. Azepane-4,5-diones; 5. Tetrahydroazepines; I. 2,3,4,5-Tetrahydrol[1H]azepines 327 $aII. 2,3,4,7-Tetrahydro[1H]azepinesIII. 2,3,6,7-Tetrahydro[1H]azepines; IV. 3,4,5,6-Tetrahydro[2H]azepines; 6. Tetrahydroazepinones; I. 1,3,4,5-Tetrahydro[2H]azepin-2-ones; II. 1,3,4,7-Tetrahydro[2H]azepin-2-ones; III. 1,3,6,7-Tetrahydro[2H]azepin-2-ones; IV. 1,5,6,7-Tetrahydro[2H]azepin-2-ones; VIII. 1,2,6,7-Tetrahydro[3H]azepin-3-ones; XII. l,2,3,7-Tetrahydro[4H]azepin-4-ones; XIII. l,5,6,7-Tetrahydro[4H]azepin-4-ones; XIV. 2,3,5,6-Tetrahydro[4H]azepin-4-ones; XV. 3,5,6,7-Tetrahydro[4H]azepin-4-ones; 7. Tetrahydroazepinediones; I. 2,3,4,5-Tetrahydro[lH]azepine-2,3-diones 327 $aV. 2,3,4,5-Tetrahydro[lH]azepine-2,4-dionesVIII. 2,3,4,5-Tetrahydro[lH]azepine-2,5-diones; IX. 2,5,6,7-Tetrahydro[lH]azepine-2,5-diones; XIV. 2,3,4,7-Tetrahydro[lH]azepine-2,7-diones; XV. 2,3,6,7-Tetrahydro[lH]azepine-2,7-diones; XXIII. 2,3,4,5-Tetrahydro[lH]azepine-4,5-diones; XXIV. 3,4,5,6-Tetrahydro[2H]azepine-4,5-diones; 8. Dihydroazepines; I. 2,3-Dihydro[lH]azepines; II. 2,5-Dihydro[lH]azepines; III. 2,7-Dihydro[lH]azepines; IV. 4,5-Dihydro[lH]azepines; V. 3,4-Dihydro[2H]azepines; VI. 3,6-Dihydro[2H]azepines; VII. 5,6-Dihydro[2H]azepines; VIII. 4,5-Dihydro[3H]azepines 327 $a9. DihydroazepinonesI. l,3-Dihydro[2H]azepin-2-ones; II. l,5-Dihydro[2H]azepin-2-ones; III. l,7-Dihydro[2H1azepin-2-ones; IV. 3,4-Dihydro[2H]azepin-2-ones; V. 3,6-Dihydro[2H]azepin-2-ones; VII. l,2-Dihydro[3H]azepin-3-ones; XV. 2,3-Dihydro[4H]azepin-4-ones; 10. Dihydroazepinediones; I. 2,3-Dihydro[lH]azepine-2,3-diones; V. 2,5-Dihydro[lH]azepine-2,5-diones; IX. 2,7-Dihydro[lH]azepine-2,7-diones; 11. Azepines; I. [lH]azepines; II. [2H]azepines; III. [3H]azepines; IV. [4H]azepines; 12. Azepinones; I. [2H]azepin-2-ones; II. [3H]azepin-3-ones; III. [4H]azepin-4-ones; Index 330 $aThe newest volume in the prestigious series The Chemistry of Heterocyclic Compounds, this work covers synthesis, reactions, properties, structure, physical chemistry and utility of monocyclic azepines. 410 0$aChemistry of heterocyclic compounds ;$vv. 56. 606 $aAzepines 606 $aHeterocyclic compounds 615 0$aAzepines. 615 0$aHeterocyclic compounds. 676 $a547.59 676 $a547/.59/05 676 $a547/.593 700 $aProctor$b George R$01649003 701 $aRedpath$b James$01649004 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830897703321 996 $aMonocyclic azepines$93997503 997 $aUNINA LEADER 02064nam 2200481z- 450 001 9910557258403321 005 20211118 035 $a(CKB)5400000000041373 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/73592 035 $a(oapen)doab73592 035 $a(EXLCZ)995400000000041373 100 $a20202111d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aHIV-Associated Immune Activation and Persistent Inflammation 210 $cFrontiers Media SA$d2020 215 $a1 online resource (147 p.) 311 08$a2-88963-438-8 330 $aThis eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact 606 $aImmunology$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $abeta-D-glucan 610 $aCXCL12 610 $adysbiosis 610 $afungal translocation 610 $aLPS 610 $amicrobial translocation 610 $anon-AIDS events 615 7$aImmunology 615 7$aMedicine and Nursing 700 $aHoenigl$b Martin$4edt$01287896 702 $aGianella$b Sara$4edt 702 $aKessler$b Harald H$4edt 702 $aHoenigl$b Martin$4oth 702 $aGianella$b Sara$4oth 702 $aKessler$b Harald H$4oth 906 $aBOOK 912 $a9910557258403321 996 $aHIV-Associated Immune Activation and Persistent Inflammation$93020538 997 $aUNINA